David A. Siegel Seres Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.09 - $9.05 $479,987 - $853,415	-94,300 Reduced 82.72%	19,700 $110,000
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $583,450 - $1.2 Million	-166,700 Reduced 59.39%	114,000 $732,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $5,400 - $15,240	-2,000 Reduced 0.71%	280,700 $963,000
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $231,840 - $325,312	36,800 Added 14.97%	282,700 $2.01 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $1.75 Million - $3.33 Million	-291,000 Reduced 54.2%	245,900 $2.05 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $2.75 Million - $11.4 Million	503,100 Added 1488.46%	536,900 $3.74 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $1.58 Million - $2.08 Million	-85,400 Reduced 71.64%	33,800 $806,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $1.29 Million - $2.11 Million	72,900 Added 157.45%	119,200 $2.45 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $295,275 - $479,170	12,700 Added 37.8%	46,300 $1.13 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $311,542 - $2.39 Million	-83,300 Reduced 71.26%	33,600 $951,000
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $83,904 - $171,120	27,600 Added 30.91%	116,900 $556,000
Q1 2020 May 15, 2020	BUY	$2.64 - $3.82 $30,888 - $44,694	11,700 Added 15.08%	89,300 $319,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $43,654 - $64,532	14,600 Added 23.17%	77,600 $268,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $37,098 - $67,392	16,200 Added 34.62%	63,000 $253,000
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $53,807 - $173,460	23,600 Added 101.72%	46,800 $151,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $28,980 - $43,260	6,000 Added 34.88%	23,200 $159,000
Q4 2018 Feb 14, 2019	SELL	$4.52 - $8.88 $7,231 - $14,208	-1,600 Reduced 8.51%	17,200 $78,000
Q3 2018 Nov 14, 2018	SELL	$7.33 - $9.23 $18,325 - $23,075	-2,500 Reduced 11.74%	18,800 $143,000
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $26,258 - $36,290	3,800 Added 21.71%	21,300 $183,000
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $132,120 - $200,880	-18,000 Reduced 50.7%	17,500 $128,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $12.64 $196,725 - $271,760	21,500 Added 153.57%	35,500 $360,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $179,340 - $235,900	14,000	14,000 $225,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

46.3M

Call Options Held

119K

Put Options Held

466K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$21.3 Million
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$5.78 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$2.21 Million
0.21% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.78M
Shares

$1.64 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.62 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account